There were many news stories this week about a new Food and Drug Administration (FDA) warning about the use of Proton Pump Inhibitor or PPI medications used to treat Gastroesophageal Reflux Disease or GERD. The FDA has decided to add more information to the medication labels warning of an increased risk of fractures associated with the long term use of these medications. The information is not new. What is new is the recommendations given to doctors and consumers about the safety and use of...
